GeoVax Labs, Inc. Warrants

$1.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (+31.43%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch GOVXW and buy or sell other stocks, options, and ETFs commission-free!

About GOVXW

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever; Zika virus and malari; human immunodeficiency virus (HIV); as well as immunotherapies for solid tumor cancers.

CEO
David A. Dodd
Employees
—
Headquarters
Smyrna, Georgia
Founded
1988
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
20.97K
High Today
$1.96
Low Today
$1.05
Open Price
$1.05
Volume
139.76K
52 Week High
$4.48
52 Week Low
$0.4917

You May Also Like

WRLD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure